VYNE Therapeutics Inc (VYNE)
2.55
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
2.63
+0.08
(+3.14%)
After-Hours: 20:00
VYNE Therapeutics Revenue (Annual): 0.424M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.424M |
| December 31, 2022 | 0.477M |
| December 31, 2021 | 0.931M |
| December 31, 2020 | 20.99M |
| Date | Value |
|---|---|
| December 31, 2019 | |
| December 31, 2018 | 10.64M |
| December 31, 2017 | 4.582M |
| December 31, 2016 | 0.674M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.424M
Minimum
2023
20.99M
Maximum
2020
5.706M
Average
0.704M
Median
Revenue (Annual) Benchmarks
| Viking Therapeutics Inc | -- |
| AN2 Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.854M |
| iBio Inc | -- |